Cancer stem cells in colorectal cancer by Bulanin, D.
Cancer stem cells in colorectal 
cancer 
Denis Bulanin, CLS, NU 2015 
Outline 
1. Anatomy of the colon 
2. Stages of CRC 
3. Crypt organization 
4. Models of tumor development 
5. Stem cells vs. CSC 
6. Alternative strategies of cancer treatment P53 and P38/MK2 
pathways 
7. Current research 
8. Future applications 
 
 
 
 
 
Colorectal cancer (CRC) is the third leading type of cancer with 1,361,000 newly 
recorded cases in 2012, accounting for more than 694,000 deaths worldwide and 
the fifth in Kazakhstan 2500-3000 cases a year.  
Anatomy of colon 
Stages of colorectal cancer 
Anatomy of the intestine 
Cell division takes place at the bottom of the crypt.  
Cells move up the vilus and shed to the lumen 
Intestinal crypt organization 
1. Enterocytes- absorption of nutrients, contain microvilli which increasing the surface area 
2. Goblet cells – secretion of mucus 
3. Enteroendocrine cells secret various hormones influencing gastrointestinal secretion or motility 
4. Panneth cells – secrete anti-bacterial proteins into crypt lumen to protect the stem cells  
Stem cells located  
at +1 and + 4 positions 
At +1 CS are actively cycling 
At +4 SC slow cycling 
Current models for development of a tumor 
Fanali C., et al., World J Gastroenterol. 2014 Jan 28; 20(4): 923–942. 
Stem cell vs. Cancer stem cell 
Stem cells  features 
Self renewal  
Multilineage differentiation 
Controlled division rate 
Niche dependent 
 
Cancer stem cell features  
Self renewal  
Multilineage differentiation  
Tumorigenic potential  
Uncontrolled/ Unlimited cell division rate 
Niche independent (often) 
High invasiveness capability 
Drug resistance  
Metastatic potential 
Genomic instability 
Existence of different pulls in one tumor 
Evolution 
The cancer stem cell theory suggests that tumors grow like normal tissues of the body, 
with stem cells at the starting point of an organized system that produces new cells to 
make a tissue grow. According to this idea, tumors contain: 
Cancer stem cells that divide and feed tumour growth. These cells can self-renew (copy 
themselves) extensively, and also produce more mature cells called transit amplifying 
cells. 
 
Transit amplifying cells that divide a certain number of times then differentiate (or 
'mature') into specialized tumor cells. 
Specialized tumor cells that do not divide and so do not contribute to tumor growth. 
According to this idea, the cells in a tumor are in a strictly organized system with cancer 
stem cells at the top of the tree, giving rise to all other cancer cells. 
 
The stochastic model of cancer growth gives a different possible explanation of tumour 
growth. This theory argues that all cancer cells have the same potential to grow and 
divide, but each cell chooses at random between self-renewal and differentiation. The 
cells in a tumor are not in an organized system – any cell has the same intrinsic potential 
to contribute to tumor growth. 
p53 P38/MK2 
Alternative strategies for cancer treatment 
Chemotherapeutic drugs as a DNA damaging agents 
P53 is necessary for DNA repair at G1 
P53 is mutated in 50% of all cancers 
 
 
Nitrogen mustards 
Nitrosoureas: 
Alkyl sulfonates 
Triazines 
temozolomide  
Ethylenimines 
http://biochemistri.es/post/83760238677 
Current and potential future research directions 
1. We aimed to evaluate the resistance development of CSC to chemotherapeutic drugs 
 a. CRCSC are grown in elevating concentrations of 5FU until they develop the 
 resistance  
 Resistance can be developed trough a wide spectrum of protective mechanisms 
 including DNA damage repair, altered cell-cycle checkpoint control, malfunction of 
 apoptosis, drug transporters, and detoxifying enzymes    
  
 b. Genomic approach using RNA sequencing of the cells that developed resistance 
 to evaluate the potential mechanism of the resistance development in CRCSC 
 
2. Using P38/MK2 cascade blockers in P53 mutants.  
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